13F Holdings
中文EN

FMC FMC CORP

Chemicals & Allied Products · NYSE · SEC CIK 37785 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-22.0%
TTM net income YoY-696.3%
TTM EPS YoY-678.8%
Revenue 3-yr CAGR-17.2%
Net income 3-yr CAGR—

Margins

Gross margin22.0%
Operating margin-97.0%
Net margin-151.2%
FCF margin13.1%
EBITDA margin-91.0%

Returns

ROE-226.7%
ROA-42.6%
ROIC (approx.)-38.4%
Asset turnover0.28x

Leverage & solvency

Liabilities / assets99.9%
Debt / equity—
Current ratio1.66x
Interest coverage-9.96x

Cash quality & payout

Operating cash flow / net income-0.10x
Accruals ratio-46.8%
Payout ratio—
Capex / revenue2.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.47B$4.25B$4.49B$5.80B$5.05B
Cost of revenue$2.18B$2.60B$2.66B$3.48B$2.88B
Gross profit$1.28B$1.65B$1.83B$2.33B$2.16B
R&D expense$266.10M$278.00M$328.80M$314.20M$304.70M
SG&A expense$684.90M$644.60M$734.30M$775.20M$714.10M
Operating income-$1.63B$506.50M$555.60M$1.14B$1.03B
Interest expense$239.60M$235.80M$237.20M$151.80M$131.10M
Pretax income-$1.89B$252.50M$300.20M$983.90M$897.80M
Income tax$314.20M-$150.90M-$1.12B$145.20M$92.50M
Net income-$2.24B$341.10M$1.32B$736.50M$739.60M
EBITDA-$1.45B$682.80M$739.90M$1.31B$1.21B
EPS (basic)-17.882.7310.555.835.76
EPS (diluted)-17.882.7210.535.815.73
Dividends declared per share1.822.322.322.171.96
Weighted avg. shares (diluted)125.16M125.36M125.53M126.71M129.15M
Balance sheet
Cash & equivalents$584.50M$357.30M$302.40M$572.00M$516.80M
Receivables$2.06B$2.90B$2.70B$2.87B$2.58B
Inventory$1.22B$1.20B$1.72B$1.65B$1.52B
Current assets$4.96B$4.96B$5.13B$5.44B$5.05B
PP&E, net$707.40M$849.70M$892.50M$849.60M$817.00M
Goodwill$0$1.51B$1.59B$1.59B$1.46B
Intangibles$2.36B$2.36B$2.47B$2.51B$2.52B
Total assets$9.69B$11.65B$11.93B$11.17B$10.67B
Current liabilities$3.76B$3.02B$3.38B$3.80B$3.52B
Short-term debt$1.31B$337.40M$934.00M$540.80M$440.80M
Long-term debt$2.77B$3.03B$3.02B$2.73B$2.73B
Total debt$4.07B$3.37B$3.96B$3.27B$3.17B
Total liabilities$7.59B$7.14B$7.49B$7.77B$7.53B
Shareholders' equity$2.07B$4.49B$4.41B$3.38B$3.12B
Net debt$3.49B$3.01B$3.66B$2.70B$2.66B
Cash flow statement
Operating cash flow-$6.20M$736.70M-$300.30M$660.00M$898.60M
Capital expenditure$96.30M$67.90M$133.90M$142.30M$100.10M
Free cash flow-$102.50M$668.80M-$434.20M$517.70M$798.50M
Investing cash flow-$99.70M$263.60M-$154.40M-$266.40M-$131.70M
Financing cash flow$386.00M-$870.10M$331.50M-$237.40M-$747.90M
Depreciation & amortization$173.60M$176.30M$184.30M$169.40M$170.90M
Stock-based compensation$24.00M$23.80M$25.90M$24.20M$17.80M
Dividends paid$291.30M$290.60M$290.50M$267.50M$247.20M
Share buybacks$0$0$75.00M$100.00M$400.00M

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.